[1]刘文烜,胡 晋,钟小丽,等.沙库巴曲缬沙坦联合八段锦对心力衰竭合并室性心律失常的临床疗效研究[J].医学信息,2025,38(09):105-109.[doi:10.3969/j.issn.1006-1959.2025.09.020]
　LIU Wenxuan,HU Jin,ZHONG Xiaoli,et al.Study on the Clinical Effect of Sacubitril/Valsartan Combined with Baduanjin on Heart Failure Complicated with Ventricular Arrhythmia[J].Journal of Medical Information,2025,38(09):105-109.[doi:10.3969/j.issn.1006-1959.2025.09.020]
点击复制

沙库巴曲缬沙坦联合八段锦对心力衰竭合并室性心律失常的临床疗效研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年09期
页码:
105-109
栏目:
论著
出版日期:
2025-05-01

文章信息/Info

Title:
Study on the Clinical Effect of Sacubitril/Valsartan Combined with Baduanjin on Heart Failure Complicated with Ventricular Arrhythmia
文章编号:
1006-1959（2025）09-0105-05
作者:
刘文烜; 胡 晋; 钟小丽; 周盛辉
上犹县中医院急诊科，江西 上犹 341200
Author(s):
LIU Wenxuan;  HU Jin;  ZHONG Xiaoli;  ZHOU Shenghui
Department of Emergency, Shangyou County Hospital of Traditional Chinese Medicine, Shangyou 341200, Jiangxi, China
关键词:
沙库巴曲缬沙坦; 八段锦; 心力衰竭; 室性心律失常
Keywords:
Sacubactril/valsartan;  Baduanjin;  Heart failure;  Ventricular arrhythmia
分类号:
R541.7；R541.6
DOI:
10.3969/j.issn.1006-1959.2025.09.020
文献标志码:
A
摘要:
目的 研究沙库巴曲缬沙坦联合八段锦对心力衰竭合并室性心律失常的临床疗效。方法 选取上犹县中医院2023年1月-10月收治的60例心力衰竭合并室性心律失常患者为研究对象，按照随机数字表法将其分为对照组和研究组，每组30例。对照组口服沙库巴曲缬沙坦钠片治疗，研究组在对照组的基础上增加中医传统功法八段锦治疗。比较两组心功能[左室舒张末期内径（LVEDd）、左室收缩末期内径（LVESd）、射血分数（EF）]、脑利钠肽前体（Pro-Bnp）、血清C反应蛋白（CRP）水平、校正QT间期离散度（QTcd）变化、6 min步行试验（6MWT）水平、临床疗效、不良事件（恶心呕吐、腹痛、肝肾心血管功能异常）发生率。结果 研究组治疗后EF值高于对照组，LVESd、LVEEd水平均低于对照组（P＜0.05）。研究组Pro-Bnp、CRP水平低于对照组（P＜0.05）。研究组QTcd水平低于对照组（P＜0.05）。研究组6MWT长于对照组（P＜0.05）。研究组治疗总有效率高于对照组（P＜0.05）。研究组不良事件发生率低于对照组（P＜0.05）。结论 沙库巴曲缬沙坦联合八段锦治疗心力衰竭合并室性心律失常的临床疗效确切，能够提高患者心功能和运动能力，降低炎症因子水平和QTcd水平，减少不良事件的发生，值得临床应用。
Abstract:
Objective To study the clinical effect of sacubitril/valsartan combined with Baduanjin on heart failure complicated with ventricular arrhythmia. Methods A total of 60 patients with heart failure complicated with ventricular arrhythmia admitted to Shangyou County Hospital of Traditional Chinese Medicine from January to October 2023 were selected as the research objects. According to the random number table method, they were divided into control group and study group, with 30 patients in each group. The control group was treated with sacubitril/valsartan sodium tablets orally, and the study group was treated with traditional Chinese medicine Baduanjin on the basis of the control group. The cardiac function [left ventricular end-diastolic diameter (LVEDd), left ventricular end-systolic diameter (LVESd), ejection fraction (EF)], brain natriuretic peptide precursor (Pro-Bnp), serum C-reactive protein (CRP) levels, corrected QT interval dispersion (QTcd) changes, six-minute walking test (6MWT) levels, clinical efficacy, and incidence of adverse events (nausea and vomiting, abdominal pain, liver and kidney cardiovascular dysfunction) were compared between the two groups. Results After treatment, the EF value of the study group was higher than that of the control group, and the levels of LVESD and LVEED were lower than those of the control group (P<0.05). The levels of Pro-Bnp and CRP in the study group were lower than those in the control group (P<0.05). The QTcd level of the study group was lower than that of the control group (P<0.05). The 6MWT of the study group was longer than that of the control group (P<0.05). The total effective rate of treatment in the study group was higher than that in the control group (P<0.05). The incidence of adverse events in the study group was lower than that in the control group (P<0.05). Conclusion Sacubitril/valsartan combined with Baduanjin has a definite clinical effect in the treatment of heart failure complicated with ventricular arrhythmia, which can improve the cardiac function and exercise capacity of patients, reduce the levels of inflammatory factors and QTcd, and reduce the occurrence of adverse events. It is worthy of clinical application.

参考文献/References:

[1]尚蒙.沙库巴曲缬沙坦对植入埋藏式心律转复除颤器慢性心力衰竭患者心功能及室性心律失常的影响[D].昆明:昆明理工大学,2023.[2]杨凯,任斐,江成功,等.沙库巴曲缬沙坦对慢性心力衰竭患者室性心律失常及心率变异性的影响[J].江苏医药,2022,48(9):905-908.[3]尚蒙,高晓龙,匡晓晖,等.沙库巴曲缬沙坦在植入埋藏式心律转复除颤器慢性心力衰竭患者中的应用[J].昆明医科大学学报,2023,44(11):63-69.[4]范婷婷,何非,王晓晨.沙库巴曲缬沙坦与缬沙坦治疗慢性心力衰竭的早期临床疗效比较[J].安徽医学,2019,40(6):618-621.[5]张常莹,刘晓宇,李晓燕,等.沙库巴曲缬沙坦对植入了心脏除颤器的心力衰竭患者室性心律失常发生的影响[J].中国心脏起搏与心电生理杂志,2021,35(4):305-309.[6]张先林,路桥,李金龙,等.沙库巴曲缬沙坦联合达格列净与射血分数减低的心力衰竭临床疗效及预后的相关性[J].中华急诊医学杂志,2022,31(10):1396-1401.[7]龚中元,张银妆,方立,等.钠-葡萄糖协同转运蛋白-2抑制剂联合沙库巴曲缬沙坦钠治疗射血分数降低的心力衰竭患者的临床研究[J].现代生物医学进展,2023,23(7):1299-1303,1357.[8]吴晓倩,赵永辉,臧小彪,等.沙库巴曲缬沙坦对心力衰竭患者植入式心脏转复除颤器治疗事件影响的研究[J].中国心血管杂志,2021,26(6):560-564.[9]杨立佳,戴红艳.沙库巴曲/缬沙坦治疗慢性心力衰竭合并室性心律失常1例[J].中国循证心血管医学杂志,2021,13(9):1135,1137.[10]杨萍,代天,张苏川.沙库巴曲缬沙坦联合芪苈强心胶囊治疗慢性收缩性心力衰竭的临床研究[J].中西医结合心脑血管病杂志,2022,20(2):268-271.[11]柳湘洁,刘晓霞.沙库巴曲缬沙坦对射血分数中间值心力衰竭患者心功能及近期预后的影响[J].临床和实验医学杂志,2021,20(16):1689-1692.[12]顾伟,李志忠.沙库巴曲缬沙坦治疗老年缺血性心肌病导致射血分数降低心力衰竭预后分析[J].中华老年医学杂志,2021,40(5):562-565.[13]张磊,丁辉.通心络胶囊联合沙库巴曲缬沙坦钠片治疗慢性心力衰竭的疗效及对患者心功能和炎症因子的影响[J].海南医学,2021,32(24):3162-3165.[14]魏云杰,王俊峰,程飞,等.沙库巴曲缬沙坦改善乳腺癌患者曲妥珠单抗所致心力衰竭的效果研究[J].实用心脑肺血管病杂志,2020,28(10):93-97.[15]卢洁,范倩.沙库巴曲缬沙坦钠片治疗慢性心力衰竭的效果观察[J].武警后勤学院学报（医学版）,2019,28(9):60-62.[16]赵妙香,舒九伟.沙库巴曲缬沙坦钠与米力农联合依那普利对扩张型心肌病心力衰竭患者心功能及日常生活能力的影响[J].山西医药杂志,2020,49(15):2018-2020.[17]何花,董大立.医疗-家庭过渡期八段锦运动对冠心病伴慢性心力衰竭患者康复的影响[J].中医药导报,2023,29(5):119-123.[18]虞君,么传为,于现庆,等.益气活血贴穴位贴敷联合八段锦治疗慢性心力衰竭的临床研究[J].中西医结合心脑血管病杂志,2022,20(1):99-101.[19]李永新,申亚婷,于慧卿,等.坐式八段锦及加味益气升降方联合西医常规疗法治疗慢性心力衰竭临床研究[J].中国中医药信息杂志,2021,28(4):116-120.[20]康正林,刘承瑞,王越,等.八段锦联合有氧耐力训练对老年稳定性冠心病合并慢性心力衰竭患者的应用效果分析[J].中国医学前沿杂志（电子版）,2021,13(2):39-42.

相似文献/References:

[1]赵晓慧,佘侃侃,蔡雨婷,等.基于Maya技术的交互式中医养生运动视频制作[J].医学信息,2018,31(18):16.[doi:10.3969/j.issn.1006-1959.2018.18.07]
　ZHAO Xiao-hui,SHE Kan-kan,CAI Yu-ting,et al.Interactive TCM Health Care Video Production Based on Maya Technology[J].Journal of Medical Information,2018,31(09):16.[doi:10.3969/j.issn.1006-1959.2018.18.07]
[2]杨晓丽,蔡益民,吴贤琳,等.八段锦对冠心病患者心脏康复干预效果的Meta分析[J].医学信息,2019,32(04):70.[doi:10.3969/j.issn.1006-1959.2019.04.024]
　YANG Xiao-li,CAI Yi-min,WU Xian-lin,et al.Meta-analysis of the Effect of Ba Duan Jin on Cardiac Rehabilitation Intervention in Patients with Coronary Heart Disease[J].Journal of Medical Information,2019,32(09):70.[doi:10.3969/j.issn.1006-1959.2019.04.024]
[3]李 龙,汪莲开.沙库巴曲缬沙坦在心力衰竭治疗中的应用[J].医学信息,2020,33(02):58.[doi:10.3969/j.issn.1006-1959.2020.02.016]
　LI Long,WANG Lian-kai.Application of Shakubatrivasartan in the Treatment of Heart Failure[J].Journal of Medical Information,2020,33(09):58.[doi:10.3969/j.issn.1006-1959.2020.02.016]
[4]袁 超.沙库巴曲缬沙坦联合比索洛尔治疗慢性心力衰竭的效果[J].医学信息,2020,33(19):135.[doi:10.3969/j.issn.1006-1959.2020.19.041]
　YUAN Chao.Effect of Sacubitril Valsartan Combined with Bisoprolol in the Treatment of Chronic Heart Failure[J].Journal of Medical Information,2020,33(09):135.[doi:10.3969/j.issn.1006-1959.2020.19.041]
[5]王晨青,李婧炜.沙库巴曲缬沙坦在心力衰竭中的应用现状[J].医学信息,2021,34(01):37.[doi:10.3969/j.issn.1006-1959.2021.01.011]
　WANG Chen-qing,LI Jing-wei.The Application Status of Sacubatril Valsartan in Heart Failure[J].Journal of Medical Information,2021,34(09):37.[doi:10.3969/j.issn.1006-1959.2021.01.011]
[6]韦怡春,易秋艳.沙库巴曲缬沙坦对心力衰竭患者抑郁的影响[J].医学信息,2021,34(23):29.[doi:10.3969/j.issn.1006-1959.2021.23.008]
　WEI Yi-chun,YI Qiu-yan.Effect of Sacubitril Valsartan on Depression in Patients with Heart Failure[J].Journal of Medical Information,2021,34(09):29.[doi:10.3969/j.issn.1006-1959.2021.23.008]
[7]熊鹏锋.沙库巴曲缬沙坦联合美托洛尔对青年扩张型心肌病患者心功能及预后的影响[J].医学信息,2022,35(20):80.[doi:10.3969/j.issn.1006-1959.2022.20.020]
　XIONG Peng-feng.Effect of Sacubitril Valsartan Combined with Metoprolol on Cardiac Function and Prognosis in Young Patients with Dilated Cardiomyopathy[J].Journal of Medical Information,2022,35(09):80.[doi:10.3969/j.issn.1006-1959.2022.20.020]
[8]龚殿炳.芪苈强心胶囊联合沙库巴曲缬沙坦治疗慢性心力衰竭的临床效果及对心室重构的影响[J].医学信息,2023,36(23):99.[doi:10.3969/j.issn.1006-1959.2023.23.025]
　GONG Dian-bing.Clinical Effect of Qili Qiangxin Capsules Combined with Sacubitril Valsartan in Treatment of Chronic Heart Failure and its Effect on Ventricular Remodeling[J].Journal of Medical Information,2023,36(09):99.[doi:10.3969/j.issn.1006-1959.2023.23.025]
[9]葛文涛,程长生,胡成坤.强心贴联合沙库巴曲缬沙坦对慢性心力衰竭患者脑钠肽水平的影响[J].医学信息,2025,38(04):132.[doi:10.3969/j.issn.1006-1959.2025.04.024]
　GE Wentao,CHENG Changsheng,HU Chengkun.Effect of Qiangxin Paste Combined with Sacubitril Valsartan on Brain Natriuretic Peptide Level in Patients with Chronic Heart Failure[J].Journal of Medical Information,2025,38(09):132.[doi:10.3969/j.issn.1006-1959.2025.04.024]
[10]邱隆霞.沙库巴曲缬沙坦对射血分数保留心功能衰竭患者临床症状及心功能的影响[J].医学信息,2025,38(09):92.[doi:10.3969/j.issn.1006-1959.2025.09.017]
　QIU Longxia.Effect of Sacubitril/Valsartan on Clinical Symptoms and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction[J].Journal of Medical Information,2025,38(09):92.[doi:10.3969/j.issn.1006-1959.2025.09.017]

更新日期/Last Update: 1900-01-01